ImpriMed Raises $8M to Commercialize AI-Driven Personalized Drug Response Prediction Service in Pet Cancer Market
GlobeNewswire
Learn More →ImpriMed Launches Advanced Precision Medicine Service for Canine Blood Cancers
PR Underground
Learn More →ImpriMed Raises $4M for Customized Cancer Treatments for Dogs
GlobeNewswire
Learn More →